ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984

NCI Cooperative Group Clinical Trials Approved

September 25, 2009

DCCR Community Oncology Program RFP Now Ready

April 27, 1979

AACR Journal Publishes a Henschke Letter Without Disclosure of Conflicts.

April 25, 2008

Kirsten Goldberg Leaves The Cancer Letter For ASCO

January 7, 2011

FDA Approves Imaging System To Detect Cervical Pre-Cancer

March 31, 2006